3 completed, 2 active not recruiting, 2 recruiting, 1 not yet recruiting. 8 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 3, Active not recruiting 2, Recruiting 2, Not yet recruiting 1 |
Follow Drug Drug Interaction (DDI): new trials by email Literature Review of Drug Drug Interaction (DDI) trials Research Report on Drug Drug Interaction (DDI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity UBT251, Metformin hydrochloride, Warfarin Sodium - Drug Drug Interaction (DDI), Pharmacokinetics and Pharmacodynamics | Phase 1 | Recruiting | The United Bio-Technology (Hengqin) Co., Ltd. | 48 | 2026-05-27 | 2026-08-25 |
| Study on the Drug Interaction Between Buagafuran and Voriconazole Buagafuran, Voriconazole - Drug Drug Interaction (DDI) | Phase 1 | Not yet recruiting | Beijing Union Pharmaceutical Factory Ltd | 18 | 2026-04-01 | 2026-03-09 |
| to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban JP-1366 and clopidogrel, JP-1366 and aspirin, JP-1366 and atorvastatin - Drug Drug Interaction (DDI) | Phase 1 | Recruiting | Onconic Therapeutics Inc. | 96 | 2025-11-17 | 2025-12-04 |
| Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects Methotrexate, Rifampicin, Cyclosporine - Drug Drug Interaction (DDI) | Phase 1 | Active not recruiting | Seoul National University Bundang Hospital | 12 | 2025-05-14 | 2025-09-29 |
| A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects SB17170, SB_MDZ - Drug Drug Interaction (DDI) | Phase 1 | Completed | SPARK Biopharma | 12 | 2025-03-27 | 2025-11-19 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. EDP-323, Itraconazole, carbamazepine - RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2025-01-27 | 2025-07-01 |
| A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates BMS-984923, Midazolam, Caffeine - Drug Drug Interaction (DDI) | Phase 1 | Active not recruiting | Allyx Therapeutics | 36 | 2024-11-04 | 2025-02-07 |
| Drug-Drug Interaction (DDI) Study for TD-9855 TD-9855, Fluvoxamine, Itraconazole - Drug Drug Interaction (DDI) | Phase 1 | Completed | Theravance Biopharma | 41 | 2018-02-28 | 2021-01-14 |
Obesity (1) · Overweight (1) · Respiratory Syncytial Virus Infections (1) · Smoking (1)
Behavior (1) · Body Weight (1) · Infections (1) · Mononegavirales Infections (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Paramyxoviridae Infections (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumovirus Infections (1) · RNA Virus Infections (1) · Signs and Symptoms (1) · Virus Diseases (1)
Atorvastatin (2) · Caffeine (2) · Itraconazole (2) · Aspirin (1) · Carbamazepine (1) · Clopidogrel (1) · Cyclosporine (1) · Dextromethorphan (1) · Digoxin (1) · Fluconazole (1) · Fluvoxamine (1) · Metformin (1) · Methotrexate (1) · Midazolam (1) · Quinidine (1)
Allyx Therapeutics (1) · Beijing Union Pharmaceutical Factory Ltd (1) · Enanta Pharmaceuticals, Inc (1) · Onconic Therapeutics Inc. (1) · SPARK Biopharma (1) · Seoul National University Bundang Hospital (1) · The United Bio-Technology (Hengqin) Co., Ltd. (1) · Theravance Biopharma (1)
South Korea (3) · United States (3) · China (2)
Hong Zhang (1) · Jae Yong Chung, Professor (1)
SB1AG087748 (1)